Perhaps the most intriguing finding was the slightly more frequent and earlier development of MBMs in patients with APC/CTNNB1 genetic aberrations who developed MM in the combined UNC-CH/Vanderbilt/CPMRI cohort compared to those patients without APC/CTNNB1 genetic aberrations. This evidence concerns the gene CTNNB1 and Miyoshi myopathy.